美国 · SEC FORM 4
DELCATH SYSTEMS, INC.
DCTH · Nasdaq · CIK 0000872912 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
2 同一窗口内观察到的 Form 4 交易行
0 sales · 2 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-03-06 · Pennell Sandra.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,947,041
- 上期报告
- 2,311,774
- 日均成交量
- 362,508
- 回补天数
- 5.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-06 | Pennell Sandra | 买入 (P) | Common Stock | 5,533 | USD 9.04 | USD 50,018 | SEC 申报 ↗ |
| 2026-03-02 | MICHEL GERARD J | 买入 (P) | Common Stock | 11,200 | USD 8.96 | USD 100,352 | SEC 申报 ↗ |
| 2025-11-21 | Sylvester John Richard | 买入 (P) | Common Stock | 4,386 | USD 8.89 | USD 38,992 | SEC 申报 ↗ |
| 2025-11-11 | MICHEL GERARD J | 买入 (P) | Common Stock | 11,500 | USD 8.53 | USD 98,095 | SEC 申报 ↗ |
| 2024-03-19 | SALAMON STEVEN A J | 买入 (P) | Common Shares | 26,882 | USD 3.72 | USD 100,001 | SEC 申报 ↗ |
| 2024-03-19 | Aharon Gil | 买入 (P) | Common Shares | 26,882 | USD 3.72 | USD 100,001 | SEC 申报 ↗ |
| 2023-12-12 | Vukovic Vojo | 买入 (P) | Common Stock | 40,000 | USD 3.00 | USD 120,000 | SEC 申报 ↗ |
| 2023-12-08 | MICHEL GERARD J | 买入 (P) | Common Stock | 34,000 | USD 2.94 | USD 99,960 | SEC 申报 ↗ |
| 2023-11-17 | Pennell Sandra | 买入 (P) | Common Stock | 30,000 | USD 2.43 | USD 72,900 | SEC 申报 ↗ |
| 2023-11-17 | Aharon Gil; Rosalind Advisors, Inc.; SALAMON STEVEN A J | 买入 (P) | Common Shares | 100,000 | USD 2.40 | USD 240,000 | SEC 申报 ↗ |
| 2023-11-16 | Vukovic Vojo | 买入 (P) | Common Stock | 60,000 | USD 2.48 | USD 148,800 | SEC 申报 ↗ |
| 2023-11-16 | Hoffman David L. | 买入 (P) | Common Stock | 40,000 | USD 2.48 | USD 99,200 | SEC 申报 ↗ |
| 2023-10-13 | Purpura John | 买入 (P) | Common Stock | 14,505 | USD 3.44 | USD 49,897 | SEC 申报 ↗ |
| 2023-08-21 | Sylvester John Richard | 买入 (P) | Common Stock | 10,550 | USD 4.80 | USD 50,640 | SEC 申报 ↗ |
| 2023-03-29 | MICHEL GERARD J | 买入 (P) | Common Stock | 19,646 | USD 4.84 | USD 95,087 | SEC 申报 ↗ |
Form 4 申报证据
6 transaction lines in the latest 365-day window; 111 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Aharon Gil; Rosalind Advisors, Inc.; SALAMON STEVEN A J | J (J) | Common Stock | 27,502 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-13 | Aharon Gil; Rosalind Advisors, Inc.; SALAMON STEVEN A J | C (C) | Common Stock | 3,627 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Pennell Sandra | 买入 (P) | Common Stock | 5,533 | USD 9.04 | USD 50,018 | SEC 申报 ↗ |
展开近期 Form 4 证据 (6 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Aharon Gil; Rosalind Advisors, Inc.; SALAMON STEVEN A J | J (J) | Common Stock | 27,502 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-13 | Aharon Gil; Rosalind Advisors, Inc.; SALAMON STEVEN A J | C (C) | Common Stock | 3,627 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Pennell Sandra | 买入 (P) | Common Stock | 5,533 | USD 9.04 | USD 50,018 | SEC 申报 ↗ |
| 2026-03-02 | MICHEL GERARD J | 买入 (P) | Common Stock | 11,200 | USD 8.96 | USD 100,352 | SEC 申报 ↗ |
| 2025-11-21 | Sylvester John Richard | 买入 (P) | Common Stock | 4,386 | USD 8.89 | USD 38,992 | SEC 申报 ↗ |
| 2025-11-11 | MICHEL GERARD J | 买入 (P) | Common Stock | 11,500 | USD 8.53 | USD 98,095 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | DCTH |
| CIK | 0000872912 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 111 transaction lines from 2020-05-06 to 2026-10-13 62 P purchase lines · 0 S sale lines · 49 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.